Clinical Trial Update: Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating the T-CID regimen (thalidomide, cyclophosphamide, oral idarubicin, and dexamethasone) in patients with multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Idarubicin (idarubicin)
• Thalidomide (thalidomide)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN